Acta OphthalmolFebruary 2024Journal Article
The use of benzalkonium chloride in topical glaucoma treatment.
Authors
No abstract available for this article.
More by Anne Hedengran
View full profile →The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
2023Acta Ophthalmol20 citations
Generic benzalkonium chloride-preserved travoprost eye drops are not identical to the branded polyquarternium-1-preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties.
2022Acta Ophthalmol14 citations
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement.
2022Am J Ophthalmol9 citations
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.